Related Experiment Video
Updated: Aug 8, 2025

06:19
Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
Published on: March 10, 2023
4.7K
ROCKETS - a novel one-for-all toolbox for light sheet microscopy in drug discovery
Joerg P J Mueller1,2, Michael Dobosz2, Nils O'Brien2
1Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.
Frontiers in Immunology
|February 27, 2023
Summary
A new protocol, Rapid Optical Clearing Kit for Enhanced Tissue Scanning (ROCKETS), enables faster, standardized whole-body tissue imaging. This advances immunotherapy research by revealing new drug target locations, like EpCAM on the tongue and in the brain.
Area of Science:
- Immunology
- Biomedical Imaging
- Preclinical Research
Background:
- Advancing immunotherapies requires better preclinical tools for target, biodistribution, safety, and efficacy assessment.
- Light sheet fluorescence microscopy (LSFM) provides fast, high-resolution imaging of large tissues but faces limitations due to laborious processing.
- Standardized protocols are needed to increase throughput and broaden LSFM applications in immunology.
Purpose of the Study:
- To develop a harmonized protocol for processing, clearing, and imaging entire mouse bodies for enhanced preclinical research.
- To apply this protocol with LSFM to study the biodistribution of an antibody targeting Epithelial Cell Adhesion Molecule (EpCAM).
- To identify novel EpCAM expression sites and assess their relevance for EpCAM-targeting immunotherapies.
Main Methods:
- Development of the Rapid Optical Clearing Kit for Enhanced Tissue Scanning (ROCKETS) protocol.
- Application of ROCKETS with LSFM for 3D imaging of whole mouse organs and bodies.
- Quantitative analysis of EpCAM distribution in mouse tissues and confirmation in human samples.
Main Results:
- ROCKETS enables comprehensive, high-resolution 3D imaging of entire mouse bodies.
- New EpCAM binding sites were identified, including gustatory papillae (tongue), choroid plexi (brain), and duodenal papillae.
- High EpCAM expression was confirmed in human tongue and duodenal tissues, highlighting potential clinical relevance.
Conclusions:
- ROCKETS combined with LSFM offers a standardized platform for preclinical evaluation of immunotherapies.
- The protocol facilitates quantitative co-localization studies within the microanatomical context of organs or whole organisms.
- Discovery of novel EpCAM sites has significant implications for the clinical translation of EpCAM-targeting immunotherapies.

